Medicare Patients Wait Average of 34 Days to See Neurologist After Referral
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 8, 2025 -- After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, according to study published online Jan. 8 in Neurology.
Chun Chieh Lin, Ph.D., from The Ohio State University in Columbus, and colleagues conducted a cross-sectional study using a 2018 to 2019 Medicare sample of patients with a new visit to a neurologist. The primary outcome was wait time between the last visit with a referring physician and the first visit with a neurologist. A total of 163,313 Medicare beneficiaries who had a new patient visit with a neurologist in 2018 to 2019 after being referred by their physician were identified.
The researchers found that the median wait time to the index neurologist visit was 34 days; 18 percent of patients waited more than 90 days. Compared with patients with back pain, those with multiple sclerosis (MS), epilepsy, and Parkinson disease (PD) had to wait an average of 29.4, 10.4, and 9.3 days longer, respectively. No significant differences were seen in wait times across race/ethnicity and sex. No significant differences were seen in wait times across regions with varying levels of neurologist availability. The wait time was extended by an average of 11 days when patients visited a neurologist located outside of their residential or referring physician's hospital referral region.
"Patients with MS, epilepsy, and PD had to wait longer to see neurologists despite requiring complicated care best provided by neurologists," the authors write. "We need innovative approaches to improve timely access to neurologists."
Several authors disclosed ties to the medical device industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-09 12:00
Read more

- Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
- American Academy of Pediatrics Sues HHS Over Vaccine Policy
- Breast Cancer Risk in Younger Women May Be Influenced by Hormone Therapy
- Screen Time May Slow Learning Skills, Study Finds
- Remote CBT-Based Therapy Yields Modest Improvements in Chronic Pain
- Fewer Opioids Being Prescribed for Low Back Pain in the Emergency Department
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions